Acadia Healthcare (NASDAQ:ACHC) Upgraded at Zacks Research

Zacks Research upgraded shares of Acadia Healthcare (NASDAQ:ACHC) from a strong sell rating to a hold rating in a research report report published on Thursday morning,Zacks.com reports.

A number of other equities analysts have also recently weighed in on the stock. UBS Group upped their price objective on shares of Acadia Healthcare from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Thursday, February 26th. Jefferies Financial Group lowered Acadia Healthcare to a “hold” rating in a research report on Thursday, January 22nd. Cantor Fitzgerald set a $17.00 price target on Acadia Healthcare in a report on Wednesday, December 3rd. Royal Bank Of Canada raised their price objective on Acadia Healthcare from $17.00 to $28.00 and gave the company an “outperform” rating in a research note on Thursday, February 26th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, January 21st. Seven analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $21.15.

Acadia Healthcare Stock Up 3.9%

NASDAQ ACHC opened at $25.62 on Thursday. The company has a quick ratio of 1.44, a current ratio of 1.55 and a debt-to-equity ratio of 1.27. Acadia Healthcare has a fifty-two week low of $11.43 and a fifty-two week high of $31.43. The business has a 50 day moving average price of $15.80 and a two-hundred day moving average price of $18.67. The stock has a market cap of $2.36 billion, a PE ratio of -2.10, a P/E/G ratio of 8.66 and a beta of 0.74.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, February 25th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.04. The company had revenue of $821.46 million for the quarter, compared to analyst estimates of $800.10 million. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. The business’s quarterly revenue was up 6.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.64 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. As a group, sell-side analysts predict that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Trading of Acadia Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the company. Allworth Financial LP grew its position in shares of Acadia Healthcare by 676.4% in the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock worth $31,000 after acquiring an additional 1,177 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the last quarter. Wells Fargo & Company MN lifted its stake in Acadia Healthcare by 208.9% during the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after purchasing an additional 1,510 shares during the last quarter. Bayforest Capital Ltd acquired a new position in Acadia Healthcare in the fourth quarter worth $52,000. Finally, Hantz Financial Services Inc. increased its stake in Acadia Healthcare by 501.9% during the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock valued at $54,000 after purchasing an additional 1,822 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.